Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:activities |
modulation of neurotransmitter systems
|
| gptkbp:developed_by |
gptkb:Alkermes
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALX-0702
|
| gptkbp:ingredients |
C19 H22 N2 O3 S
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:manager |
oral
|
| gptkbp:research_areas |
treatment of schizophrenia
|
| gptkbp:targets |
CY P2 D6 enzyme
|
| gptkbp:type_of |
123456-78-9
|
| gptkbp:weight |
342.45 g/mol
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|